Major Alzheimer's drug trial halted early
Disease control
Terminated
This study tested whether a drug called simufilam could slow memory and thinking decline in people with mild-to-moderate Alzheimer's disease. About 1,125 participants took either the drug or a placebo pill twice daily for 76 weeks. The trial was terminated early, and researchers …
Phase: PHASE3 • Sponsor: Cassava Sciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC